Ceribell (CBLL) Change in Acquisitions & Divestments (2025 - 2026)

Ceribell (CBLL) posted Change in Acquisitions & Divestments of $50.0 million for Q1 2026, up 2.67% on a QoQ basis from $48.7 million in Q4 2025.

Ceribell (CBLL) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

Ceribell's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $50.0 million for Q1 2026.

Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $144.2 million (changed N/A YoY) and the FY2025 annual result came in at $94.2 million, changed N/A from the prior year.
Change in Acquisitions & Divestments was $50.0 million for Q1 2026 at Ceribell, up from $48.7 million in the prior quarter.
Across five years, Change in Acquisitions & Divestments topped out at $50.0 million in Q1 2026 and bottomed at $6.0 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	181.33 Bn	174.04 Bn	6.27 Bn
2	Stryker	128.11 Bn	125.23 Bn	3.81 Bn
3	Medtronic	107.76 Bn	98.54 Bn	6.41 Bn
4	Boston Scientific	67.95 Bn	66.50 Bn	3.61 Bn
5	Edwards Lifesciences	47.64 Bn	43.97 Bn	1.29 Bn
6	GE HealthCare Technologies	28.43 Bn	26.14 Bn	1.98 Bn
7	Dexcom	28.31 Bn	27.20 Bn	750.30 Mn
8	Smith & Nephew	26.77 Bn	26.19 Bn	-
9	Koninklijke Philips	25.33 Bn	22.21 Bn	2.07 Bn
10	Ceribell	667.39 Mn	526.21 Mn	23.12 Mn

Download Data